Net Income (Loss) Attributable to Parent in USD of BIOLASE, INC from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
BIOLASE, INC quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q2 2010 to Q3 2024.
  • BIOLASE, INC Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2024 was -$1,428,000.000, a 68.9% increase year-over-year.
  • BIOLASE, INC Net Income (Loss) Attributable to Parent for the twelve months ending 30 Sep 2024 was -$16,037,000.000, a 36.3% increase year-over-year.
  • BIOLASE, INC annual Net Income (Loss) Attributable to Parent for 2023 was -$20,632,000.000, a 27.9% increase from 2022.
  • BIOLASE, INC annual Net Income (Loss) Attributable to Parent for 2022 was -$28,634,000.000, a 77.2% decline from 2021.
  • BIOLASE, INC annual Net Income (Loss) Attributable to Parent for 2021 was -$16,158,000.000, a 3.99% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

BIOLASE, INC Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$16,037,000 -$1,428,000 +$3,161,000 +68.9% 01 Jul 2024 30 Sep 2024 10-Q 07 Nov 2024
Q2 2024 -$19,198,000 -$2,798,000 +$2,070,000 +42.5% 01 Apr 2024 30 Jun 2024 10-Q 08 Aug 2024
Q1 2024 -$21,268,000 -$6,485,000 -$636,000 -10.9% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2024
Q4 2023 -$20,632,000 -$5,326,000 +$4,534,000 +46% 01 Oct 2023 31 Dec 2023 10-K 21 Mar 2024
Q3 2023 -$25,166,000 -$4,589,000 +$3,798,000 +45.3% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024
Q2 2023 -$28,964,000 -$4,868,000 +$743,000 +13.2% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024
Q1 2023 -$29,707,000 -$5,849,000 -$1,073,000 -22.5% 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024
Q4 2022 -$28,634,000 -$9,860,000 -$4,581,000 -86.8% 01 Oct 2022 31 Dec 2022 10-K 21 Mar 2024
Q3 2022 -$24,053,000 -$8,387,000 -$5,111,000 -1.6% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 -$18,942,000 -$5,611,000 -$4,909,000 -7% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023
Q1 2022 -$14,033,000 -$4,776,000 +$2,125,000 +30.8% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023
Q4 2021 -$16,158,000 -$5,279,000 +$859,000 +14% 01 Oct 2021 31 Dec 2021 10-K 21 Mar 2024
Q3 2021 -$17,017,000 -$3,276,000 -$3,288,000 -274% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022
Q2 2021 -$13,729,000 -$702,000 +$3,995,000 +85.1% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022
Q1 2021 -$17,724,000 -$6,901,000 -$895,000 -14.9% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022
Q4 2020 -$16,829,000 -$6,138,000 -$2,560,000 -71.5% 01 Oct 2020 31 Dec 2020 10-K 28 Mar 2023
Q3 2020 -$14,269,000 $12,000 +$5,490,000 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021
Q2 2020 -$19,759,000 -$4,697,000 -$798,000 -20.5% 01 Apr 2020 30 Jun 2020 10-Q 13 Aug 2021
Q1 2020 -$18,961,000 -$6,006,000 -$1,106,000 -22.6% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021
Q4 2019 -$17,855,000 -$3,578,000 +$3,341,000 +48.3% 01 Oct 2019 31 Dec 2019 10-K 17 Mar 2022
Q3 2019 -$21,196,000 -$5,478,000 -$813,000 -17.4% 01 Jul 2019 30 Sep 2019 10-Q 13 Nov 2020
Q2 2019 -$20,383,000 -$3,899,000 +$1,012,000 +20.6% 01 Apr 2019 30 Jun 2019 10-Q 14 Aug 2020
Q1 2019 -$21,395,000 -$4,900,000 +$121,000 +2.4% 01 Jan 2019 31 Mar 2019 10-Q 08 May 2020
Q4 2018 -$21,516,000 -$6,919,000 -$3,077,000 -80.1% 01 Oct 2018 31 Dec 2018 10-K 31 Mar 2021
Q3 2018 -$18,439,000 -$4,665,000 -$53,000 -1.1% 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019
Q2 2018 -$18,386,000 -$4,911,000 -$622,000 -14.5% 01 Apr 2018 30 Jun 2018 10-Q 09 Aug 2019
Q1 2018 -$17,764,000 -$5,021,000 -$913,000 -22.2% 01 Jan 2018 31 Mar 2018 10-Q 10 May 2019
Q4 2017 -$16,851,000 -$3,842,000 +$585,000 +13.2% 01 Oct 2017 31 Dec 2017 10-K 30 Mar 2020
Q3 2017 -$17,436,000 -$4,612,000 -$1,466,000 -46.6% 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018
Q2 2017 -$15,970,000 -$4,289,000 -$756,000 -21.4% 01 Apr 2017 30 Jun 2017 10-Q 13 Aug 2018
Q1 2017 -$15,214,000 -$4,108,000 +$157,000 +3.7% 01 Jan 2017 31 Mar 2017 10-Q 04 May 2018
Q4 2016 -$15,371,000 -$4,427,000 -$1,969,000 -80.1% 01 Oct 2016 31 Dec 2016 10-K 08 Mar 2019
Q3 2016 -$13,402,000 -$3,146,000 +$2,197,000 +41.1% 01 Jul 2016 30 Sep 2016 10-Q 01 Nov 2017
Q2 2016 -$15,599,000 -$3,533,000 +$3,508,000 +49.8% 01 Apr 2016 30 Jun 2016 10-Q 07 Aug 2017
Q1 2016 -$19,107,000 -$4,265,000 +$1,171,000 +21.5% 01 Jan 2016 31 Mar 2016 10-Q 04 May 2017
Q4 2015 -$20,278,000 -$2,458,000 +$1,647,000 +40.1% 01 Oct 2015 31 Dec 2015 10-K 14 Mar 2018
Q3 2015 -$21,925,000 -$5,343,000 -$1,848,000 -52.9% 01 Jul 2015 30 Sep 2015 10-Q 08 Nov 2016
Q2 2015 -$20,077,000 -$7,041,000 -$602,000 -9.3% 01 Apr 2015 30 Jun 2015 10-Q 01 Aug 2016
Q1 2015 -$19,475,000 -$5,436,000 -$549,000 -11.2% 01 Jan 2015 31 Mar 2015 10-Q 09 May 2016
Q4 2014 -$18,926,000 -$4,105,000 -$1,871,000 -83.8% 01 Oct 2014 31 Dec 2014 10-K 10 Mar 2017
Q3 2014 -$17,055,000 -$3,495,000 +$554,000 +13.7% 01 Jul 2014 30 Sep 2014 10-Q 06 Nov 2015
Q2 2014 -$17,609,000 -$6,439,000 -$3,871,000 -1.5% 01 Apr 2014 30 Jun 2014 10-Q 07 Aug 2015
Q1 2014 -$13,738,000 -$4,887,000 -$2,256,000 -85.7% 01 Jan 2014 31 Mar 2014 10-Q 01 May 2015
Q4 2013 -$11,482,000 -$2,234,000 -$3,275,000 -3.1% 01 Oct 2013 31 Dec 2013 10-K 11 Mar 2016
Q3 2013 -$8,207,000 -$4,049,000 -$3,501,000 -6.4% 01 Jul 2013 30 Sep 2013 10-Q 07 Nov 2014
Q2 2013 -$4,706,000 -$2,568,000 -$691,000 -36.8% 01 Apr 2013 30 Jun 2013 10-Q 08 Aug 2014
Q1 2013 -$4,015,000 -$2,631,000 -$959,000 -57.4% 01 Jan 2013 31 Mar 2013 10-Q 12 May 2014
Q4 2012 -$3,056,000 $1,041,000 +$3,071,000 01 Oct 2012 31 Dec 2012 10-K 06 Mar 2015
Q3 2012 -$6,127,000 -$548,000 +$405,000 +42.5% 01 Jul 2012 30 Sep 2012 10-Q 12 Nov 2013
Q2 2012 -$6,532,000 -$1,877,000 -$1,124,000 -1.5% 01 Apr 2012 30 Jun 2012 10-Q 09 Aug 2013
Q1 2012 -$5,408,000 -$1,672,000 -$922,000 -1.2% 01 Jan 2012 31 Mar 2012 10-Q 10 May 2013
Q4 2011 -$4,486,000 -$2,030,000 01 Oct 2011 31 Dec 2011 10-K 17 Mar 2014
Q3 2011 -$953,000 +$1,773,000 +65% 01 Jul 2011 30 Sep 2011 10-Q 09 Nov 2012
Q2 2011 -$753,000 +$3,411,000 +81.9% 01 Apr 2011 30 Jun 2011 10-Q/A 06 Sep 2012
Q1 2011 -$750,000 01 Jan 2011 31 Mar 2011 10-Q 10 May 2012
Q3 2010 -$2,726,000 01 Jul 2010 30 Sep 2010 10-Q 10 Nov 2011
Q2 2010 -$4,164,000 01 Apr 2010 30 Jun 2010 10-Q 11 Aug 2011

BIOLASE, INC Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$20,632,000 +$8,002,000 +27.9% 01 Jan 2023 31 Dec 2023 10-K 21 Mar 2024
2022 -$28,634,000 -$12,476,000 -77.2% 01 Jan 2022 31 Dec 2022 10-K 21 Mar 2024
2021 -$16,158,000 +$671,000 +4% 01 Jan 2021 31 Dec 2021 10-K 21 Mar 2024
2020 -$16,829,000 +$1,026,000 +5.7% 01 Jan 2020 31 Dec 2020 10-K 28 Mar 2023
2019 -$17,855,000 +$3,661,000 +17% 01 Jan 2019 31 Dec 2019 10-K 17 Mar 2022
2018 -$21,516,000 -$4,665,000 -27.7% 01 Jan 2018 31 Dec 2018 10-K 31 Mar 2021
2017 -$16,851,000 -$1,480,000 -9.6% 01 Jan 2017 31 Dec 2017 10-K 30 Mar 2020
2016 -$15,371,000 +$4,907,000 +24.2% 01 Jan 2016 31 Dec 2016 10-K 08 Mar 2019
2015 -$20,278,000 -$1,352,000 -7.1% 01 Jan 2015 31 Dec 2015 10-K 14 Mar 2018
2014 -$18,926,000 -$7,444,000 -64.8% 01 Jan 2014 31 Dec 2014 10-K 10 Mar 2017
2013 -$11,482,000 -$8,426,000 -2.8% 01 Jan 2013 31 Dec 2013 10-K 11 Mar 2016
2012 -$3,056,000 +$1,430,000 +31.9% 01 Jan 2012 31 Dec 2012 10-K 06 Mar 2015
2011 -$4,486,000 +$7,535,000 +62.7% 01 Jan 2011 31 Dec 2011 10-K 17 Mar 2014
2010 -$12,021,000 01 Jan 2010 31 Dec 2010 10-K 15 Mar 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.